The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.

As part of the initiative, the Department of Health and Human Services has asked the National Academies of Sciences, Engineering, and Medicine to release consensus reports this fall on vaccine research and development; vaccine distribution and supply chains; public health interventions and countermeasures; and global coordination, partnerships and financing.

NAM will host a public workshop this spring to hear from experts and gather feedback to inform the reports.

Related News Articles

Headline
The Food and Drug Administration last week issued an emergency use authorization to Becton, Dickinson and Company for its sodium citrate blood specimen…
Headline
Pfizer today said its COVID-19 vaccine will receive a priority review from the Food and Drug Administration, indicating that Pfizer has completed its…
Headline
The Food and Drug Administration today revoked its emergency use authorization for the Curative SARS-Cov-2 Assay test because the manufacturer has…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will convene July 22 to discuss a pair of recent issues related…
Headline
Johnson & Johnson yesterday was notified that the Food and Drug Administration now will require that the company add to the label of its COVID-19…
Headline
Responding last month to an AHA letter, the Centers for Medicare & Medicaid Services said it will continue to remain flexible in its approach to surveys if…